Clinical development of monoclonal antibody-based drugs in HIV and HCV diseases

Today there are many licensed antiviral drugs, but the emergence of drug resistant strains sometimes invalidates the effects of the current therapies used in the treatment of infectious diseases. Compared to conventional antiviral drugs, monoclonal antibodies (mAbs) used as pharmacological molecules...

Descripción completa

Detalles Bibliográficos
Autores principales: Flego, Michela, Ascione, Alessandro, Cianfriglia, Maurizio, Vella, Stefano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3565905/
https://www.ncbi.nlm.nih.gov/pubmed/23289632
http://dx.doi.org/10.1186/1741-7015-11-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3565905/
https://www.ncbi.nlm.nih.gov/pubmed/23289632
http://dx.doi.org/10.1186/1741-7015-11-4

Ejemplares similares